About Schweirische Arbeitsgruppe fur klinische Krebsforschung
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Schweirische Arbeitsgruppe fur klinische Krebsforschung
During the past decade, Schweirische Arbeitsgruppe fur klinische Krebsforschung conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Schweirische Arbeitsgruppe fur klinische Krebsforschung"
#1 collaborator was "Amgen" with 1 trials as a collaborator and "Fondation ARC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Schweirische Arbeitsgruppe fur klinische Krebsforschung
According to Clinical.Site data, the most researched conditions in "Schweirische Arbeitsgruppe fur klinische Krebsforschung" are
"Diffuse Large Cell Lymphoma" (2 trials), "Lymphoma, Large-Cell, Diffuse" (2 trials) and "B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Schweirische Arbeitsgruppe fur klinische Krebsforschung" in a lesser frequency.
Clinical Trials Intervention Types at Schweirische Arbeitsgruppe fur klinische Krebsforschung
Most popular intervention types in "Schweirische Arbeitsgruppe fur klinische Krebsforschung" are "Drug" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (2 trials), "Autologous Stem Cell Transplantation" (1 trials), "BCNU" (1 trials), "Bleomycin" (1 trials) and "Carboplatine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Schweirische Arbeitsgruppe fur klinische Krebsforschung
The vast majority of trials in "Schweirische Arbeitsgruppe fur klinische Krebsforschung" are
5 trials for "All" genders.
Clinical Trials Status at Schweirische Arbeitsgruppe fur klinische Krebsforschung
Currently, there are NaN active trials in "Schweirische Arbeitsgruppe fur klinische Krebsforschung".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Schweirische Arbeitsgruppe fur klinische Krebsforschung,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Schweirische Arbeitsgruppe fur klinische Krebsforschung, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".